Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Malignant Neoplasms
|
1641 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.100 | 0.909 | 11 | 2002 | 2017 | |||||
Xeroderma Pigmentosum, Complementation Group D
|
111 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.100 | 0.917 | 12 | 2003 | 2016 | |||||
Carcinoma of lung
|
1204 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.100 | 1.000 | 14 | 2001 | 2014 | |||||
Malignant neoplasm of lung
|
1142 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.100 | 1.000 | 14 | 2001 | 2014 | |||||
Primary malignant neoplasm of lung
|
981 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.100 | 1.000 | 14 | 2001 | 2014 | |||||
Bladder Neoplasm
|
281 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.080 | 1.000 | 8 | 2007 | 2014 | |||||
Carcinoma of bladder
|
309 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.080 | 1.000 | 8 | 2007 | 2014 | |||||
Malignant neoplasm of urinary bladder
|
316 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.080 | 1.000 | 8 | 2007 | 2014 | |||||
Squamous cell carcinoma of esophagus
|
329 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.060 | 1.000 | 6 | 2002 | 2016 | |||||
Neoplasms
|
1644 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.040 | 1.000 | 4 | 2008 | 2019 | |||||
Adult Non-Hodgkin Lymphoma
|
39 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.030 | 1.000 | 3 | 2014 | 2017 | |||||
Childhood Non-Hodgkin Lymphoma
|
39 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.030 | 1.000 | 3 | 2014 | 2017 | |||||
Lymphoma, Non-Hodgkin, Familial
|
79 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.030 | 1.000 | 3 | 2014 | 2017 | |||||
melanoma
|
515 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.030 | 1.000 | 3 | 2005 | 2018 | |||||
Squamous cell carcinoma
|
257 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.030 | 1.000 | 3 | 2002 | 2015 | |||||
Esophageal carcinoma
|
272 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.020 | 1.000 | 2 | 2014 | 2019 | |||||
Esophageal Neoplasms
|
270 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.020 | 1.000 | 2 | 2014 | 2019 | |||||
Liver carcinoma
|
942 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.020 | 1.000 | 2 | 2014 | 2016 | |||||
Malignant neoplasm of esophagus
|
214 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.020 | 1.000 | 2 | 2014 | 2019 | |||||
Acute monocytic leukemia
|
22 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Adenocarcinoma Of Esophagus
|
81 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Adenomatous Polyps
|
20 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.010 | 1.000 | 1 | 2005 | 2005 | |||||
Adult Lymphoma
|
66 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||
Anemia, severe
|
6 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
Azoospermia
|
70 | 0.557 | 0.640 | 19 | 45364001 | missense variant | C/A;T | snv | 7.1E-06; 0.29 | 0.010 | 1.000 | 1 | 2008 | 2008 |